An ALS Therapeutic Assembly Modulator Target in Peripheral Blood Mononuclear Cells: Implications for ALS Pathophysiology, Therapeutics, and Diagnostics
S. Yu, M. Michon, A. F. Lingappa, K. Paulvannan, D. Solas, K. A. Staats, J. Ichida, D. Dey, J. Rosenfeld, V. R. Lingappa
The paper identifies a multi-protein complex in PBMCs as a target for ALS therapeutic assembly modulators, showing altered composition in ALS patients and responsiveness to treatment.
bioRxiv · Mar 28, 2024Physiology